[{"Assets_0_Q2_USD":172046128.0,"CommonStockSharesOutstanding_0_Q2_shares":31523474.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-26301452.0,"NetIncomeLoss_1_Q2_USD":-17164646.0,"NetIncomeLoss_2_Q2_USD":-31569139.0,"StockholdersEquity_0_Q2_USD":116505260.0,"Ticker":"ARVN","CIK":"1655759","name":"ARVINAS, INC.","OfficialName":"Arvinas Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3525475441.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190805"}]